Character | Response | |
---|---|---|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: clinical specimens (vaginosis)
DNA G+C(%): 65
|
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
amoxicillin: S(0.25)
Augmentin: S(0.063)
aztreonam: R(>64)
oxacillin: S(1)
penicillin: S(0.125)
imipenem: S(0.063)
meropenem: S(0.25)
|
cefazolin: S(<0.125)
cefuroxime: S(0.5)
|
amikacin: S(1)
gentamicin: S(0.125)
netilmycin: S(0.125)
tobramycin: S(0.125)
|
azithromycin: S(0.063)
erythromycin: S(0.03)
clarithromycin: S(<0.03)
|
ciprofloxacin: S(0.25)
norfloxacin: S(2)
sparfloxacin: S(0.25)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
tetracycline: S(2)
|
teicoplanin: S(0.5)
vancomycin: S(0.5)
|
rifampicin: S(0.063)
|
chloramphenicol: S(2)
fosfomycin: R(>256)
|
clindamycin: S(0.125)
fusidic-acid: S(0.125)
|